A 76-year-old woman with non-valvular atrial fibrillation presents for review. She has hypertension and a prior ischaemic stroke. Her CHA₂DS₂-VASc score is 5. She is in rate-controlled atrial fibrillation on metoprolol, with no history of major bleeding or falls. Which option best reduces her risk of further stroke?